You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antiangiogenesis

Showing 1 - 25 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cervical Cancer Trial (Tislelizumab, Sitravatinib)

Not yet recruiting
  • Metastatic Cervical Cancer
  • (no location specified)
Jan 31, 2023

Hereditary Hemorrhagic Telangiectasia, HHT, Rendu Osler Weber Disease Trial in Madrid (Registry)

Recruiting
  • Hereditary Hemorrhagic Telangiectasia
  • +2 more
  • Registry
  • Madrid, Spain
    Hospital Universitario Ramón y Cajal
Sep 30, 2022

EGFR Positive NSCLC Trial in Goyang-Si (Erlotinib plus Bevacizumab, Erlotinib)

Active, not recruiting
  • EGFR Positive Non-small Cell Lung Cancer
  • Goyang-Si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Ovarian Cancer Trial in France (Pazopanib, Paclitaxel)

Completed
  • Ovarian Cancer
  • Avignon, France
  • +35 more
Feb 23, 2022

Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Bronx, Manhasset, New York (aflibercept)

Terminated
Has Results
  • Stage II Multiple Myeloma
  • Stage III Multiple Myeloma
  • aflibercept
  • Bronx, New York
  • +5 more
Jan 29, 2021

Progress Free Survival (PFS) and Overall Survival (OS) Trial in Guangzhou (Bevacizumab Injection, Nivolumab)

Completed
  • Progress Free Survival (PFS) and Overall Survival (OS)
  • Guangzhou, Guangdong, China
    Fuda Cnacer Hospital
Sep 1, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab,

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Bevacizumab+Toripalimab+gemcitabine, adjuvant with Bevacizumab and Toripalimab
  • Bevacizumab+Toripalimab+gemcitabine, adjuvant with Toripalimab
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 18, 2022

Venous Thromboembolism, Ovarian Cancer Trial in Sarasota, Durham (Aspirin)

Completed
Has Results
  • Venous Thromboembolism
  • Ovarian Cancer
  • Sarasota, Florida
  • +1 more
Sep 6, 2022

Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

Not yet recruiting
  • Untreated Advanced or Recurrent Thymic Carcinomas
  • Chuo, Tokyo, Japan
    National Cancer Center Hospital
Apr 16, 2023

Breast Cancer Trial in Xining (Sintilimab+Apatinib+Albumin-Bound Paclitaxel(Nab-Paclitaxel)+Carboplatin)

Recruiting
  • Breast Cancer
  • Sintilimab+Apatinib+Albumin-Bound Paclitaxel(Nab-Paclitaxel)+Carboplatin
  • Xining, Qinghai, China
    Affiliated Hospital of Qinghai University
Apr 21, 2022

Cervical Cancer Trial in Chongqing (niraparib combined with brivanib, niraparib combined with toripalimab)

Recruiting
  • Cervical Cancer
  • niraparib combined with brivanib
  • niraparib combined with toripalimab
  • Chongqing, Chongqing, China
    Chongqing Cancer Hospital
May 19, 2021

Renal Cell Carcinoma Trial in Omaha, Cleveland, Philadelphia (Axitinib)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Omaha, Nebraska
  • +2 more
Jul 26, 2021

DCIS Trial in Orange (Anastrozole)

Completed
Has Results
  • DCIS
  • Orange, California
    Chao Family Comprehensive Cancer Center
Apr 19, 2021

Breast Tumor Female Trial in Hangzhou (anlotinib, fulvestrant)

Recruiting
  • Breast Neoplasm Female
  • anlotinib, fulvestrant
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 10, 2021

Hepatocellular Carcinoma Trial in Houston (Lenvatinib, Transcatheter Arterial Chemoembolization)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Houston, Texas
    Houston Methodist Research Institute
Dec 10, 2021

Epidermolysis Bullosa Simplex, Epidermolysis Bullosa Simplex Kobner, Weber-Cockayne Syndrome Trial in Palo Alto (Sirolimus, 2%,

Completed
Has Results
  • Epidermolysis Bullosa Simplex
  • +2 more
  • Palo Alto, California
    Stanford University
Feb 25, 2022

Pancreatic Cancer Trial in Shanghai (Fruquintinib,Albumin Paclitaxel,Gemcitabine)

Recruiting
  • Pancreatic Cancer
  • Fruquintinib,Albumin Paclitaxel,Gemcitabine
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 29, 2021

Biliary Tract Cancer, Programmed Cell Death 1 Ligand 1 Gene Mutation, Targeted Molecular Therapy Trial in Beijing (Camrelizumab,

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • Beijing, Beijing, China
    Beijing Friendship Hospital
Jan 20, 2021

Hepatocellular Carcinoma Trial in Nanning (PD-1 antibody, TACE)

Unknown status
  • Hepatocellular Carcinoma
  • PD-1 antibody
  • TACE
  • Nanning, Guangxi, China
    Affiliated Tumor Hospital of Guangxi Medical University
Apr 12, 2019

Metastatic Triple Negative Breast Cancer, Safety Issues, Efficacy Trial in Assiut (Bevacizumab)

Completed
  • Metastatic Triple Negative Breast Cancer
  • +2 more
  • Assiut, Assuit, Egypt
    Clinical Oncology Departement Assuit University Hospital
Mar 7, 2021

Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma, Prostate Adenocarcinoma Trial in Portland, Seattle

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Biopsy of Prostate
  • +3 more
  • Portland, Oregon
  • +2 more
Sep 19, 2019

Sarcoma, Alveolar Soft Part Trial run by the NCI (AZD2171)

Active, not recruiting
Has Results
  • Sarcoma, Alveolar Soft Part
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 11, 2022

Natural History of Patients With Brain and Spinal Cord Tumors

Completed
  • Astrocytoma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 11, 2019

    NSCLC Trial in Changzhou (Apatinib Mesylate tablet combined with S-1 capsules)

    Completed
    • Non-small Cell Lung Cancer
    • Apatinib Mesylate tablet combined with S-1 capsules
    • Changzhou, Jiangsu, China
      Changzhou Cancer Hospital of Soochow University
    Dec 9, 2019

    Recurrent High-Grade Gliomas, Progressive Low-Grade Gliomas, Malignant Gliomas Trial run by the NCI (Steroids, ZD6474)

    Completed
    • Recurrent High-Grade Gliomas
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 4, 2019